Basic Information
Magnolia Neurosciences aims to discover and develop proprietary, selective, drug-like small molecule therapies to prevent neuronal cell death, thereby providing novel treatment options for patients with neurodegenerative and related diseases.
Magnolia Neurosciences Corporation
NewYork,NewYork,United States of America
15~50 people
January 01, 2018
info@magnolianeurosciences.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios